Target intelligence / Profile preview

Ras-related protein Rab-40C (RAB40C)

Target
RAB40C
Molecular classification
Small GTPase, Enzyme (GTPase), Ubiquitin ligase complex component, Monomeric G protein (Ras superfamily, Rab subfamily)
01

Overview

Ras-related protein Rab-40C (RAB40C) is a small GTPase enzyme, member of the Rab subfamily of the Ras superfamily of monomeric G proteins, which are key regulators of vesicular trafficking in eukaryotic cells. RAB40C acts as a substrate-recognition component of the ECS(RAB40C) E3 ubiquitin ligase complex, directing ubiquitination and degradation of specific target proteins. It modulates cell migration by inhibiting protein phosphatase 6 complex activity and affecting focal adhesion assembly, and negatively regulates the accumulation of lipid droplets. RAB40C is expressed in diverse tissues and is upregulated in multiple human cancers, with a significant role in tumor progression, immune regulation, and as a prognostic biomarker. Elevated expression is associated with altered immune cell infiltration, including CD4 T cells, macrophages, and regulatory T cells, and correlates with poor prognosis in several cancer types, highlighting its potential as a therapeutic target and biomarker in oncology.

Other names
RARLRASL8CRar-like proteinRas-like protein family member 8CSOCS box-containing protein RAR3
02

Mechanism of action

No drugs directly targeting RAB40C are reported; mechanisms for targeting would likely include inhibition of its GTPase activity or interference with its function in ubiquitin ligase complexes

03

Biological functions

Intracellular membrane trafficking (vesicle formation, movement, fusion)Regulation of exocytosisProtein ubiquitination and degradationNegative regulation of lipid droplet accumulationRegulation of cell migration via focal adhesion dynamicsImmunomodulation (correlation with immune cell infiltration and immune checkpoint pathways)
04

Disease associations

Cancer (notably lung squamous cell carcinoma, breast cancer, prostate cancer, ovarian cancer, and others)Prognostic biomarker in multiple cancersImmune regulation in tumor microenvironment
05

Safety considerations

No specific therapeutic safety concerns reported; potential challenges may include effects on immune regulation and off-target effects on cellular trafficking due to its role in membrane transport and protein degradation
06

Biomarkers

Prognostic biomarker for lung squamous cell carcinoma, breast cancer, and others (elevated expression linked to poorer prognosis in several tumors)Associated with microsatellite instability and immune infiltration signatures in cancers

Beyond the preview

Go deeper on Ras-related protein Rab-40C (RAB40C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-40C (RAB40C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call